pulmoПульмонологияPULMONOLOGIYA0869-01892541-9617Scientific and Practical Journal “PULMONOLOGIYA” LLCpulmo-3723Research ArticleПЕРЕДОВАЯ СТАТЬЯEDITORIALГенная терапия наследственных заболеваний — реальность и перспективыGenom therapy of hereditary diseases the reality and perspectivesСамильчукЕ. И.SamilchukH. I.
Москва
Институт пульмонологии М3 РФRussian Federation1993240420220169Copyright © Самильчук Е.И., 20222022Самильчук Е.И.Samilchuk H.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.pulmonology.ru/pulm/article/view/3723
.
ReferencesСамильчук Е. И, Лапин Б. А. Наследственный дефицит альфа-1-антитрипсина: клинические проявления, методы диагностики, перспективы лечения // Тер. арх.— 1988.— № 8.— С. 141 — 144.Самильчук Е. И, Лапин Б. А. Наследственный дефицит альфа-1-антитрипсина: клинические проявления, методы диагностики, перспективы лечения // Тер. арх.— 1988.— № 8.— С. 141 — 144.Чучалин А. Г., Самильчук Е. Я. Муковисцидоз— состояние проблемы // Там же.— 1993.— № 3.— С. 3—9.Чучалин А. Г., Самильчук Е. Я. Муковисцидоз— состояние проблемы // Там же.— 1993.— № 3.— С. 3—9.Anderson W. F. Human gene therapy // Science.— 1992.— Vol. 256.— P. 808—813.Anderson W. F. Human gene therapy // Science.— 1992.— Vol. 256.— P. 808—813.Clarke L. L., Grubb B. R., Gabriel S. E. et al. Defective epithelial chloride transport in a gene-targeted mouse model of cystic fibrosis // Ibid.— Vol. 257.— P. 1125— 1128.Clarke L. L., Grubb B. R., Gabriel S. E. et al. Defective epithelial chloride transport in a gene-targeted mouse model of cystic fibrosis // Ibid.— Vol. 257.— P. 1125— 1128.Crystal R. G., Brantly M. L., Hubbard R. C. et al. The alphal-antitrypsin gene and its mutations, clinical consequences and strategies for therapy // Chest.— 1989.— Vol. 95.— P. 196—208.Crystal R. G., Brantly M. L., Hubbard R. C. et al. The alphal-antitrypsin gene and its mutations, clinical consequences and strategies for therapy // Chest.— 1989.— Vol. 95.— P. 196—208.Collins F. S. Cystic fibrosis: molecular biology and therapeutic implication // Science.— 1992.— Vol. 256.— P. 774—779.Collins F. S. Cystic fibrosis: molecular biology and therapeutic implication // Science.— 1992.— Vol. 256.— P. 774—779.Culvert K. W., Anderson W. F., Blaese R. M. Lymphocyte gene therapy // Hum. Gene Ther.— 1991.— Vol. 2.— P. 107—109.Culvert K. W., Anderson W. F., Blaese R. M. Lymphocyte gene therapy // Hum. Gene Ther.— 1991.— Vol. 2.— P. 107—109.Drumm M. L., Pope H. A., Cliff W. H. et al. Correction of cystic fibrosis defect in vitro by retrovirus-mediated gene transfer // Cell.— 1990.— Vol. 62.— P. 1227—■ 1233.Drumm M. L., Pope H. A., Cliff W. H. et al. Correction of cystic fibrosis defect in vitro by retrovirus-mediated gene transfer // Cell.— 1990.— Vol. 62.— P. 1227—■ 1233.“Ex vivo gene therapy of familial hypercholesterolemia” // Hum. Gene Ther.— 1992.— Vol. 3.— P. 179— 232.“Ex vivo gene therapy of familial hypercholesterolemia” // Hum. Gene Ther.— 1992.— Vol. 3.— P. 179— 232.Jaffe H. A., Danel C., Longenecker G. et al. Adenovirusmediated in vivo gene transfer and Expression in normal rat liver // Nature Genet.— 1992.— Vol. 1.— P. 372—384.Jaffe H. A., Danel C., Longenecker G. et al. Adenovirusmediated in vivo gene transfer and Expression in normal rat liver // Nature Genet.— 1992.— Vol. 1.— P. 372—384.Lemarchand P., Jaffe H. A., Dannel C. et al. Adenovirusmediated transfer of a recombinant human al-antitrypsin cDNA to human endothelial cells // Proc. Natl. Acad. Sci. USA.— 1992.— Vol. 89.— P. 6482—6486.Lemarchand P., Jaffe H. A., Dannel C. et al. Adenovirusmediated transfer of a recombinant human al-antitrypsin cDNA to human endothelial cells // Proc. Natl. Acad. Sci. USA.— 1992.— Vol. 89.— P. 6482—6486.Olsen J. C., Johnson L. G., Stutts M. J. et al. Correction of the apical membrane chloride permeability defect in polarized cystic fibrosis airway epithelia following retroviral-mediated gene transfer // Hum. Gene Ther.— 1992.— Vol. 3.— P. 253—266.Olsen J. C., Johnson L. G., Stutts M. J. et al. Correction of the apical membrane chloride permeability defect in polarized cystic fibrosis airway epithelia following retroviral-mediated gene transfer // Hum. Gene Ther.— 1992.— Vol. 3.— P. 253—266.Rich D. P., Anderson M. P., Gregory R. J. et al. Expression of cystic fibrosis transmembrane conductance ragueator corrects defective chloride channeh gggulatiou in cnstic fibrosis airway epithelial cells // Nature.— 1990.— Vol. 347.— P. 358—363.Rich D. P., Anderson M. P., Gregory R. J. et al. Expression of cystic fibrosis transmembrane conductance ragueator corrects defective chloride channeh gggulatiou in cnstic fibrosis airway epithelial cells // Nature.— 1990.— Vol. 347.— P. 358—363.Rosenfeld M., Siegfried W., Yoshimura K. et al. Adenovirus-mediated transfer of a recombinant alpha-l-antitrypsin gene to the lung epithelium in vivo // Science.— 1991.— Vol. 252.— P. 431—434.Rosenfeld M., Siegfried W., Yoshimura K. et al. Adenovirus-mediated transfer of a recombinant alpha-l-antitrypsin gene to the lung epithelium in vivo // Science.— 1991.— Vol. 252.— P. 431—434.Rosenfeld M, Yoshimura K-, Trapnell B. C. et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium // Cell.— 1992.— Vol. 68.— P. 143—145.Rosenfeld M, Yoshimura K-, Trapnell B. C. et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium // Cell.— 1992.— Vol. 68.— P. 143—145.Snouwaert J. N., Brigman K. K., Latour A. M. et al. An animal model for cystic fibrosis made by gene targeting // Science.— 1992.,Vol. 257— P. 1083—1088.Snouwaert J. N., Brigman K. K., Latour A. M. et al. An animal model for cystic fibrosis made by gene targeting // Science.— 1992.,Vol. 257— P. 1083—1088.“Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase (ADA) deficiency with autologous lymphocytes transduced with a human ada gene” // Hum. Gene Ther.— 1990.— Vol. 1.— P. 327— 362.“Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase (ADA) deficiency with autologous lymphocytes transduced with a human ada gene” // Hum. Gene Ther.— 1990.— Vol. 1.— P. 327— 362.
The authors declare that there are no conflicts of interest present.